We are witnessing a rapid worldwide increase in the incidence of papillary thyroid
carcinoma (PTC) in the last thirty years. Extensive implementation of cancer screening and …

The debate on the appropriate treatment of patients with papillary thyroid cancer (PTC) has
persisted for several decades. The main controversies focus on the extent of surgery, the …

Papillary thyroid cancer (PTC) patients treated with thyroidectomy and radioiodine remnant
ablation (RRA) often have detectable TSH-stimulated thyroglobulin (Tg) levels without …

Active Surveillance is a non-invasive strategy designed to identify a minority of patients with
low-risk papillary thyroid carcinoma who might experience clinical progression and benefit …

Opinion statement Papillary thyroid cancer (PTC), the most common thyroid malignancy, is
associated with an excellent prognosis. Overall survival is more than 90%. The first-line …

Opinion statement The incidence of thyroid cancer has been increasing over the past 30
years, and it is now the seventh most common cancer in women. Papillary thyroid cancer is …

Background: Papillary thyroid carcinoma (PTC) generally has an indolent course and
favorable prognosis. However, an optimal treatment strategy for asymptomatic PTC is not …

Importance Unlike for prostate cancer, active surveillance for thyroid cancer has not
achieved wide adoption. The parameters by which this approach is feasible are also not well …

OBJECTIVE Thyroid cancer is the commonest endocrine malignancy, yet management
remains controversial. Many endocrinologists advocate diagnosis by fine needle aspiration …

We have read with great interest the article by Mazzaferri et al. that appeared in a recent
issue of JCEM (1). The issue of serum thyroglobulin (TG) after stimulation with recombinant …